Dermatology
Latest News
Choosing which biologic to prescribe for psoriasis
In cases of primary failure, consider revisiting the diagnosis, Dr. April Armstrong advised.
Latest News
Spironolactone safe, effective option for women with hidradenitis suppurativa
“Combining different treatment options that target different pathophysiologic factors is usually required to achieve adequate disease control in...
Commentary
Can zoo poo help manage diabetic foot ulcers?
The unexpected ingredient in this potentially transformative therapy? Feces from endangered species, sourced from Yorkshire Wildlife Park.
Latest News
FDA issues letter regarding lebrikizumab review for atopic dermatitis
The agency cited concerns related to an inspection of a third-party contract manufacturer.
Latest News
Study finds inflammatory bowel disease risk higher in children, adults with atopic dermatitis
AD has been associated with an increasing number of comorbidities, including IBD, but studies linking AD with IBD have had mixed results,...
Latest News
These adverse events linked to improved cancer prognosis
Emerging evidence suggests that cutaneous immune-related adverse events may be linked with favorable outcomes among patients with cancer who...
Latest News
Does the number of primary melanomas affect survival?
To compare 10-year melanoma-specific mortality and overall mortality between people with multiple primary melanomas and a single primary melanoma...
From the Journals
Hidradenitis suppurativa experts reach consensus on treatment outcome measures
“The intent of these recommendations is to provide an objective framework with both clinician and patient input that can facilitate bidirectional...
Latest News
Most adults with alopecia areata untreated 1 year after diagnosis
During the first year after diagnosis, 66.4% of patients received at least one treatment for AA at one or more time points.
Latest News
European Commission grants approval of ritlecitinib for severe alopecia areata
In June of 2023, ritlecitinib was approved by the FDA for treatment of severe alopecia areata in people ages 12 and older in the United States.
Latest News
When treating scars, ‘rehabilitation’ is the goal, not perfection
Most scars respond best to treatments with ablative and nonablative fractional lasers tuned to gentle settings, according to Victor Ross, MD.